Erratum: Unnatural amino acid side chains as S1, S1′, and S2′ probes yield cationic antimicrobial peptides with stability toward chymotryptic degradation (Journal of Medicinal Chemistry (2010) 53 (5558) DOI: 10.1021/jm1006337);Unnatural amino acid side chains as S1, S1', and S2' probes yield cationic antimicrobial peptides with stability toward chymotryptic degradation

Journal of Medicinal Chemistry

Volumn 53, Issue 15, 2010, Pages 5558-5566

  Karstad, Rasmus ^a   Isaksen, Geir ^a   Brandsdal, Bjørn Olav ^a   Svendsen, John Sigurd ^a   Svenson, Johan ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; ARGININE; CHYMOTRYPSIN; LACTOFERRICIN; POLYPEPTIDE ANTIBIOTIC AGENT; TRIPEPTIDE; TRYPTOPHAN;

AMINO ACID SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BINDING SITE; ESCHERICHIA COLI; HALF LIFE TIME; HUMAN; HUMAN CELL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR DOCKING; MOLECULAR MODEL; MOLECULAR PROBE; NONHUMAN; PHARMACOPHORE; PROTEIN DEGRADATION; PROTEIN STABILITY; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

EID: 77955449819     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm101066n     Document Type: Erratum

References (62)

1. Hedstrom, L. Serine protease mechanism and specificity Chem. Rev. 2002, 102, 4501-4523
2. Vajda, T.; Szabo, T. Specificity of Trypsin and Alpha-Chymotrypsin Towards Neutral Substrates Biochim. Biophys. Hung. 1976, 11, 287-294
3. Schechte., I; Berger, A. On Size of Active Site in Proteases. I. Papain Biochem. Biophys. Res. Commun. 1967, 27, 157
4. Hedstrom, L.; Szilagyi, L.; Rutter, W. J. Converting Trypsin to Chymotrypsin - The Role of Surface Loops Science 1992, 255, 1249-1253
5. Ma, W. Z.; Tang, C.; Lai, L. H. Specificity of trypsin and chymotrypsin: loop-motion-controlled dynamic correlation as a determinant Biophys. J. 2005, 89, 1183-1193
6. Perona, J. J.; Craik, C. S. Evolutionary divergence of substrate specificity within the chymotrypsin-like serine protease fold J. Biol. Chem. 1997, 272, 29987-29990
7. Werle, M.; Bernkop-Schnurch, A. Strategies to improve plasma half life time of peptide and protein drugs Amino Acids 2006, 30, 351-367
8. Nestor, J. J. The Medicinal Chemistry of Peptides Curr. Med. Chem. 2009, 16, 4399-4418
9. Lee, V. H. L. Enzymatic Barriers to Peptide and Protein-Absorption Crit. Rev. Ther. Drug Carrier Syst. 1988, 5, 69-97
10. Aurelio, L.; Brownlee, R. T. C.; Hughes, A. B. Synthetic preparation of N -methyl-alpha-amino acids Chem. Rev. 2004, 104, 5823-5846
11. Harris, A. G. Somatostatin and Somatostatin Analogs - Pharmacokinetics and Pharmacodynamic Effects Gut 1994, 35, S1-S4
12. Osapay, G.; Prokai, L.; Kim, H. S.; Medzihradszky, K. F.; Coy, D. H.; Liapakis, G.; Reisine, T.; Melacini, G.; Zhu, Q.; Wang, S. H. H.; Mattern, R. H.; Goodman, M. Lanthionine-somatostatin analogs: Synthesis, characterization, biological activity, and enzymatic stability studies J. Med. Chem. 1997, 40, 2241-2251
13. Rozek, A.; Powers, J. P. S.; Friedrich, C. L.; Hancock, R. E. W. Structure-based design of an indolicidin peptide analogue with increased protease stability Biochemistry 2003, 42, 14130-14138
14. Nestor, J. J.; Tahilramani, R.; Ho, T. L.; McRae, G. I.; Vickery, B. H. Luteinizing-Hormone-Releasing Hormone Antagonists Containing Very Hydrophobic Amino Acids J. Med. Chem. 1984, 27, 1170-1174
15. Leung, D.; Abbenante, G.; Fairlie, D. P. Protease inhibitors: current status and future prospects J. Med. Chem. 2000, 43, 305-341
16. Morishita, I.; Morishita, M.; Takayama, K.; Machida, Y.; Nagai, T. Hypoglycemic Effect of Novel Oral Microspheres of Insulin with Protease Inhibitor in Normal and Diabetic Rats Int. J. Pharm. 1992, 78, 9-16
17. Zasloff, M. Antimicrobial peptides of multicellular organisms Nature 2002, 415, 389-395
18. Marr, A. K.; Gooderham, W. J.; Hancock, R. E. W. Antibacterial peptides for therapeutic use: obstacles and realistic outlook Curr. Opin. Pharm. 2006, 6, 468-472
19. Hancock, R. E. W.; Sahl, H. G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies Nature Biotechnol. 2006, 24, 1551-1557
20. Haug, B. E.; Strom, M. B.; Svendsen, J. S. M. The medicinal chemistry of short lactoferricin-based antibacterial peptides Curr. Med. Chem. 2007, 14, 1-18
21. Haug, B. E.; Stensen, W.; Kalaaji, M.; Rekdal, O.; Svendsen, J. S. Synthetic antimicrobial peptidomimetics with therapeutic potential J. Med. Chem. 2008, 51, 4306-4314
22. Melo, M. N.; Ferre, R.; Castanho, M. OPINION antimicrobial peptides: linking partition, activity and high membrane-bound concentrations Nature Rev. Microbiol. 2009, 7, 245-250
23. Sharma, R. K.; Reddy, R. P.; Tegge, W.; Jain, R. Discovery of Trp-His and His-Arg Analogues as New Structural Classes of Short Antimicrobial Peptides J. Med. Chem. 2009, 52, 7421-7431
24. Bremner, J. B.; Keller, P. A.; Pyne, S. G.; Boyle, T. P.; Brkic, Z.; David, D. M.; Garas, A.; Morgan, J.; Robertson, M.; Somphol, K.; Miller, M. H.; Howe, A. S.; Ambrose, P.; Bhavnani, S.; Fritsche, T. R.; Biedenbach, D. J.; Jones, R. N.; Buckheit, R. W.; Watson, K. M.; Baylis, D.; Coates, J. A.; Deadman, J.; Jeevarajah, D.; McCracken, A.; Rhodes, D. I. Binaphthyl-Based Dicationic Peptoids with Therapeutic Potential Angew. Chem. 2010, 49, 537-540
25. Hansen, T.; Alst, T.; Havelkova, M.; Strom, M. B. Antimicrobial Activity of Small Beta-Peptidomimeties Based on the Pharmacophore Model of Short Cationic Antimicrobial Peptides J. Med. Chem. 2010, 53, 595-606
26. Strom, M. B.; Haug, B. E.; Skar, M. L.; Stensen, W.; Stiberg, T.; Svendsen, J. S. The pharmacophore of short cationic antibacterial peptides J. Med. Chem. 2003, 46, 1567-1570
27. Svenson, J.; Vergote, V.; Karstad, R.; Burvenich, C.; Svendsen, J. S.; De Spiegeleer, B. Metabolic Fate of Lactoferricin-Based Antimicrobial Peptides: Effect of Truncation and Incorporation of Amino Acid Analogs on the In Vitro Metabolic Stability J. Pharm. Exp. Ther. 2010, 332, 1032-1039
28. Svenson, J.; Stensen, W.; Brandsdal, B. O.; Haug, B. E.; Monrad, J.; Svendsen, J. S. Antimicrobial peptides with stability toward tryptic degradation Biochemistry 2008, 47, 3777-3788
29. Lu, W. Y.; Apostol, I.; Qasim, M. A.; Warne, N.; Wynn, R.; Zhang, W. L.; Anderson, S.; Chiang, Y. W.; Ogin, E.; Rothberg, I.; Ryan, K.; Laskowski, M. Binding of amino acid side-chains to S-1 cavities of serine proteinases J. Mol. Biol. 1997, 266, 441-461
30. Fei, Y. J.; Kanai, Y.; Nussberger, S.; Ganapathy, V.; Leibach, F. H.; Romero, M. F.; Singh, S. K.; Boron, W. F.; Hediger, M. A. Expression Cloning of a Mammalian Proton-Coupled Oligopeptide Transporter Nature 1994, 368, 563-566 (Pubitemid 24118776)
31. Hedstrom, L.; Perona, J. J.; Rutter, W. J. Converting Trypsin to Chymotrypsin - Residue-172 Is a Substrate-Specificity Determinant Biochemistry 1994, 33, 8757-8763
32. Perona, J. J.; Craik, C. S. Structural Basis of Substrate-Specificity in the Serine Proteases Protein Sci. 1995, 4, 337-360
33. Svenson, J.; Brandsdal, B. O.; Stensen, W.; Svendsen, J. S. Albumin binding of short cationic antimicrobial micropeptides and its influence on the in vitro bactericidal effect J. Med. Chem. 2007, 50, 3334-3339
34. Svenson, J.; Karstad, R.; Flaten, G. E.; Brandsdal, B. O.; Brandl, M.; Svendsen, J. S. Altered Activity and Physicochemical Properties of Short Cationic Antimicrobial Peptides by Incorporation of Arginine Analogues Mol. Pharmaceutics 2009, 6, 996-1005
35. Haug, B. E.; Stensen, W.; Stiberg, T.; Svendsen, J. S. Bulky nonproteinogenic amino acids permit the design of very small and effective cationic antibacterial peptides J. Med. Chem. 2004, 47, 4159-4162
36. Magnet, S.; Blanchard, J. S. Molecular insights into aminoglycoside action and resistance Chem. Rev. 2005, 105, 477-497
37. Taber, H. W.; Mueller, J. P.; Miller, P. F.; Arrow, A. S. Bacterial Uptake of Aminoglycoside Antibiotics Microbiol. Rev. 1987, 51, 439-457
38. Czapinska, H.; Otlewski, J. Structural and energetic determinants of the S-1-site specificity in serine proteases Eur. J. Biochem. 1999, 260, 571-595
39. Leavitt, S.; Freire, E. Direct measurement of protein binding energetics by isothermal titration calorimetry Curr. Opin. Struct. Biol. 2001, 11, 560-566
40. Ward, W. H. J.; Holdgate, G. A. Isothermal titration calorimetry in drug discovery. In Progress in Medicinal Chemistry, Vol. 38; Elsevier Science: Amsterdam, 2001; Vol. 38, pp 309 - 376.
41. Schellenberger, V.; Turck, C. W.; Rutter, W. J. Role of the S' Subsites in Serine-Protease Catalysis - Active-Site Mapping of Rat Chymotrypsin, Rat Trypsin, Alpha-Lytic Protease, and Cercarial Protease from Schistosoma-Mansoni Biochemistry 1994, 33, 4251-4257
42. Kurth, T.; Ullmann, D.; Jakubke, H. D.; Hedstrom, L. Converting trypsin to chymotrypsin: structural determinants of S1' specificity Biochemistry 1997, 36, 10098-10104
43. Grzesiak, A.; Helland, R.; Smalas, A. O.; Krowarsch, D.; Dadlez, M.; Otlewski, J. Substitutions at the P-1 ' position in BPTI strongly affect the association energy with serine proteinases J. Mol. Biol. 2000, 301, 205-217
44. Tyndall, J. D. A.; Nall, T.; Fairlie, D. P. Proteases universally recognize beta strands in their active sites Chem. Rev. 2005, 105, 973-999
45. Rekdal, O.; Andersen, J.; Vorland, L. H.; Svendsen, J. S. Construction and synthesis of lactoferricin derivatives with enhanced antibacterial activity J. Pept. Sci. 1999, 5, 32-45
46. Chongsiriwatana, N. P.; Patch, J. A.; Czyzewski, A. M.; Dohm, M. T.; Ivankin, A.; Gidalevitz, D.; Zuckermann, R. N.; Barron, A. E. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 2794-2799
47. Scheidig, A. J.; Hynes, T. R.; Pelletier, L. A.; Wells, J. A.; Kossiakoff, A. A. Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimer's amyloid beta-protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): Engineering of inhibitors with altered specificities Protein Sci. 1997, 6, 1806-1824
48. Atherton, E.; Fox, H.; Harkiss, D.; Logan, C. J.; Sheppard, R. C.; Williams, B. J. Mild Procedure for Solid-Phase Peptide-Synthesis - Use of Fluorenylmethoxycarbonylamino Acids J. Chem. Soc. 1978, 537-539
49. Jensen, K. J.; Alsina, J.; Songster, M. F.; Vagner, J.; Albericio, F.; Barany, G. Backbone Amide Linker (BAL) strategy for solid-phase synthesis of C-terminal-modified and cyclic peptides J. Am. Chem. Soc. 1998, 120, 5441-5452
50. Fara, M. A.; Diaz-Mochon, J. J.; Bradley, M. Microwave-assisted coupling with DIC/HOBt for the synthesis of difficult peptoids and fluorescently labelled peptides - a gentle heat goes a long way Tetrahedron Lett. 2006, 47, 1011-1014
51. Christensen, T. Qualitative Test for Monitoring Coupling Completeness in Solid-Phase Peptide-Synthesis Using Chloranil Acta Chem. Scand. 1979, 33, 763-766
52. Amsterdam, D. Susceptibility testing of antimicrobials in liquid media. In Antibiotics in Laboratory Medicine, 4th ed.; Lorian, V., Ed.; Williams and Wilkins: Philadelphia, 1996; pp 75 - 78.
53. Sajgo, M.; Low, M.; Kisfaludy, L. Enzymatic Digestibility of Peptides Containing tert -Butyltryptophan Residues Z. Physiol. Chem. 1979, 360, 9-12
54. http://www-users.med.cornell.edu/-spon/picu/calc/halfcalc.htm.
55. Maestro, 9.0; Schrödinger, LLC: New York, 2009.
56. MacroModel, 9.6; Schrödinger, LLC: New York, 2008.
57. Kaminski, G. A.; Friesner, R. A.; Tirado-Rives, J.; Jorgensen, W. L. Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides J. Phys. Chem. B 2001, 105, 6474-6487
58. Polak, E.; Ribiere, G. Note on Convergence of Conjugate Direction Methods Rev. Fr. D, Inf. Rech. Oper. 1969, 3, 35
59. LigPrep, 2.3; Schrödinger, LLC: New York, 2009.
60. Czapinska, H.; Helland, R.; Smalas, A. O.; Otlewski, J. Crystal structures of five bovine chymotrypsin complexes with P1BPTI variants J. Mol. Biol. 2004, 344, 1005-1020
61. Glide, 5.5; Schrödinger, LLC: New York, 2009.
62. The PyMol Molecular Graphics System, 1.0r2; Schrödinger, LLC: New York, 2009.